Role of sorafenib in HCC patients with compromised liver function

被引：30

作者：

Di Maio, Massimo ^{[1
]}

Daniele, Bruno ^{[2
]}

Perrone, Francesco ^{[1
]}

机构：

[1] Natl Canc Inst G Pascale Fdn, Clin Trial Unit, I-80131 Naples, Italy

[2] G Rummo Hosp, Med Oncol Unit, Benevento, Italy

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2009年 / 6卷 / 09期

关键词：

ADVANCED HEPATOCELLULAR-CARCINOMA; CIRRHOSIS; STAGE;

D O I：

10.1038/nrclinonc.2009.114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：505 / 506

页数：2

共 10 条

[1] Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis? [J].

Abou-Alfa, G. K. ;

Amadori, D. ;

Santoro, A. ;

Figer, A. ;

De Greve, J. ;

Lathia, C. ;

Voliotis, D. ;

Anderson, S. ;

Moscovici, M. ;

Ricci, S. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[2] Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].

Cheng, Ann-Lii ;

Kang, Yoon-Koo ;

Chen, Zhendong ;

Tsao, Chao-Jung ;

Qin, Shukui ;

Kim, Jun Suk ;

Luo, Rongcheng ;

Feng, Jifeng ;

Ye, Shenglong ;

Yang, Tsai-Sheng ;

Xu, Jianming ;

Sun, Yan ;

Liang, Houjie ;

Liu, Jiwei ;

Wang, Jiejun ;

Tak, Won Young ;

Pan, Hongming ;

Burock, Karin ;

Zou, Jessie ;

Voliotis, Dimitris ;

Guan, Zhongzhen .

LANCET ONCOLOGY, 2009, 10 (01) :25-34

[3] Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma [J].

Kane, Robert C. ;

Farrell, Ann T. ;

Madabushi, Rajanikanth ;

Booth, Brian ;

Chattopadhyay, Somesh ;

Sridhara, Rajeshwari ;

Justice, Robert ;

Pazdur, Richard .

ONCOLOGIST, 2009, 14 (01) :95-100

[4] Sorafenib in advanced hepatocellular carcinoma [J].

Llovet, Josep M. ;

Ricci, Sergio ;

Mazzaferro, Vincenzo ;

Hilgard, Philip ;

Gane, Edward ;

Blanc, Jean-Frederic ;

Cosme de Oliveira, Andre ;

Santoro, Armando ;

Raoul, Jean-Luc ;

Forner, Alejandro ;

Schwartz, Myron ;

Porta, Camillo ;

Zeuzem, Stefan ;

Bolondi, Luigi ;

Greten, Tim F. ;

Galle, Peter R. ;

Seitz, Jean-Francois ;

Borbath, Ivan ;

Haussinger, Dieter ;

Giannaris, Tom ;

Shan, Minghua ;

Moscovici, Marius ;

Voliotis, Dimitris ;

Bruix, Jordi .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390

[5] Design and endpoints of clinical trials in hepatocellular carcinoma [J].

Llovet, Josep M. ;

Di Bisceglie, Adrian M. ;

Bruix, Jordi ;

Kramer, Barnett S. ;

Lencioni, Riccardo ;

Zhu, Andrew X. ;

Sherman, Morris ;

Schwartz, Myron ;

Lotze, Michael ;

Talwalkar, Jayant ;

Gores, Gregory J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (10) :698-711

[6] Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301 [J].

Miller, Antonius A. ;

Murry, Daryl J. ;

Owzar, Kouros ;

Hollis, Donna R. ;

Kennedy, Erin B. ;

Abou-Alfa, Ghassan ;

Desai, Apurva ;

Hwang, Jimmy ;

Villalona-Calero, Miguel A. ;

Dees, E. Claire ;

Lewis, Lionel D. ;

Fakih, Marwan G. ;

Edelman, Martin J. ;

Millard, Fred ;

Frank, Richard C. ;

Hohl, Raymond J. ;

Ratain, Mark J. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) :1800-1805

[7] Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis [J].

Pinter, Matthias ;

Sieghart, Wolfgang ;

Graziadei, Ivo ;

Vogel, Wolfgang ;

Maieron, Andreas ;

Koenigsberg, Robert ;

Weissmann, Adalbert ;

Kornek, Gabriela ;

Plank, Christina ;

Peck-Radosavljevic, Markus .

ONCOLOGIST, 2009, 14 (01) :70-76

[8] TRANSECTION OF ESOPHAGUS FOR BLEEDING ESOPHAGEAL VARICES [J].

PUGH, RNH ;

MURRAYLY.IM ;

DAWSON, JL ;

PIETRONI, MC ;

WILLIAMS, R .

BRITISH JOURNAL OF SURGERY, 1973, 60 (08) :646-649

[9]

Wörns MA, 2009, J CLIN GASTROENTEROL, V43, P489, DOI 10.1097/MCG.0b013e31818ddfc6

[10] Commentary: Sorafenib Use in Patients with Advanced Hepatocellular Carcinoma and Underlying Child-Pugh B Cirrhosis-Evidence and Controversy [J].

Zhu, Andrew X. ;

Clark, Jeffrey W. .

ONCOLOGIST, 2009, 14 (01) :67-69

← 1 →